INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 2.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $403,000 | -16.6% | 2,430 | +21.5% | 0.40% | -2.2% |
| Q2 2015 | $483,000 | -14.4% | 2,000 | 0.0% | 0.41% | -5.5% |
| Q1 2015 | $564,000 | -83.5% | 2,000 | -90.9% | 0.43% | -84.0% |
| Q4 2014 | $3,416,000 | +622.2% | 21,900 | +995.0% | 2.70% | +466.5% |
| Q3 2014 | $473,000 | 0.0% | 2,000 | 0.0% | 0.48% | +6.5% |
| Q2 2014 | $473,000 | -28.3% | 2,000 | 0.0% | 0.45% | -21.0% |
| Q1 2014 | $660,000 | +0.8% | 2,000 | -79.2% | 0.57% | -15.9% |
| Q4 2013 | $655,000 | -1.2% | 9,598 | 0.0% | 0.67% | -6.9% |
| Q3 2013 | $663,000 | +48.0% | 9,598 | -4.0% | 0.72% | +10.4% |
| Q2 2013 | $448,000 | – | 10,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |